Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignant blue nevus]

R Rupec1, F Eckert, T Ruzicka

  • 1Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|March 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiobiology and modelling in Brachytherapy: A review inspired by the ESTRO Brachytherapy pre-meeting course.

Clinical and translational radiation oncology·2024
Same author

Single chest drain is not inferior to double chest drain after robotic esophagectomy: a propensity score-matched analysis.

Frontiers in surgery·2023
Same author

Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2021
Same author

Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.

Clinical and translational radiation oncology·2018
Same author

Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.

Acta neurologica Scandinavica·2016
Same author

Automatic delineation of tumor volumes by co-segmentation of combined PET/MR data.

Physics in medicine and biology·2015
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

A rare malignant blue nevus case is presented, highlighting diagnostic challenges. Histological and immunohistochemical analyses confirmed the diagnosis, differentiating it from melanoma.

Area of Science:

  • Dermatopathology
  • Oncology
  • Histology

Background:

  • Malignant blue nevus is a rare melanocytic tumor.
  • Differential diagnosis includes melanoma and benign blue nevi.
  • Accurate diagnosis is crucial for appropriate patient management.

Observation:

  • A 35-year-old male presented with a suspected malignant blue nevus.
  • Differential diagnoses considered were uncommon melanocytic nevus and malignant melanoma.
  • Histological examination was performed for definitive diagnosis.

Findings:

  • Tumor cells showed a strong positive reaction for vimentin and S-100 protein.
  • Immunohistochemical studies confirmed tumor cell reactivity with the HMB-45 antibody.
  • These findings support the diagnosis of malignant blue nevus.

Related Experiment Videos

Implications:

  • This case underscores the importance of thorough histopathological and immunohistochemical evaluation.
  • Accurate diagnosis aids in distinguishing malignant blue nevus from other melanocytic lesions.
  • Understanding these markers is key for oncologists and dermatopathologists.